Spindle Cell Sarcoma Treatment Companies

ID: MRFR/Pharma/5005-HCR

90 Pages

Rahul Gotadki

Last Updated: February 16, 2025

Spindle cell sarcoma is a type of soft tissue sarcoma characterized by the presence of spindle-shaped cells. Treatment for spindle cell sarcoma often involves a multidisciplinary approach, including surgery, radiation therapy, and, in some cases, systemic treatments. Companies in the healthcare and biopharmaceutical sectors play various roles in the development and provision of treatments for spindle cell sarcoma.

Spindle Cell Sarcoma Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.34%

2024 Market Size$ 2.61 Million

2025 Market Size$ 2.81 Million

2035 Market Size$ 5.16 Million

Key Players

Bristol-Myers Squibb

Merck & Co.

Novartis

Roche

Pfizer

Eli Lilly and Company

Trends

Personalized Medicine Adoption
Emergence of Novel Therapies
Increased Awareness and Education

Opportunities

Market Growth Projections
Increased Research Funding
Advancements in Treatment Modalities

Summary Table of Contents Segmentation Methodology Download PDF

Top Industry Leaders in the Spindle Cell Sarcoma Treatment Market

Spindle Cell Sarcoma Treatment Key Companies

Latest Spindle Cell Sarcoma Treatment Companies Update

Jan 2024PharmaEngine Received FDA Fast Track designation for their pevonimod, a novel oral therapy targeting the PI3K/AKT pathway for advanced spindle cell sarcoma.Partnered with leading cancer centers to conduct Phase 3 clinical trials evaluating the efficacy and safety of pevonimod in combination with standard chemotherapy.

Morphotek Announced positive Phase 2 data demonstrating the potential of their anti-PD-1 antibody, MOR2084, in combination with pembrolizumab for treating inoperable spindle cell sarcoma.Collaborated with regulatory agencies to expedite the clinical development and potential approval of MOR2084 for spindle cell sarcoma treatment.

Blueprint Medicines Corporation (US) Received Breakthrough Therapy designation from the FDA for their RET inhibitor, pralsetinib, for treating patients with RET-fusion positive spindle cell sarcoma.Expanded their access programs to provide pralsetinib to eligible patients with spindle cell sarcoma while they participate in ongoing clinical trials.

Eli Lilly and Company (US) Initiated a Phase 2 clinical trial evaluating their targeted therapy, abemaciclib, in combination with irinotecan for treating advanced spindle cell sarcoma.Partnered with academic institutions to explore the use of advanced genomic profiling and personalized medicine approaches for spindle cell sarcoma management.

National Cancer Institute (NCI) (US) Launched a new clinical trial investigating the effectiveness of pembrolizumab in combination with other targeted therapies for treating certain high-risk spindle cell sarcomas.Focused on funding collaborative research initiatives and clinical trials exploring diverse treatment options and improving outcomes for spindle cell sarcoma patients.

List of Spindle Cell Sarcoma Treatment Key Companies in The Market

PharmaEngine, Inc
Morphotek Inc
Threshold Pharmaceutical
Merck KGaA
NantCell Inc
NanoCarrier Co., Ltd
Athenex Inc.

Customize Report

Certified Researchers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Spindle Cell Sarcoma Treatment Companies

Top Industry Leaders in the Spindle Cell Sarcoma Treatment Market

Related Reports

Customer Stories